Clinical manifestation, course and treatment results of Coats disease in children

Purpose: to analyze the clinical manifestations, course, and results of treatment of Coats disease in children. Materials and methods. We performed a retrospective analysis of medical records of 59 patients with Coats retinitis (83 % were boys) who had been comprehensively examined and treated between 2018 and 2021. After the diagnosis was verified, the children were hospitalized for treatment. Retinal laser coagulation was performed on 61 eyes, angiogenesis inhibitors were administered on 1 eye, and 5 eyes received microsurgical interventions. Results. At the time of disease detection, the children’s age varied from 1 to 16 years. In 97 % of cases, the process was unilateral. An improvement of the anatomical condition and the eye-preserving effect were achieved in 87 %. Visual acuity could only be increased in 19 eyes (31.1 %), all with the initial or the advanced stages of Coats retinitis. Proceeding from our experience, the analysis of polymorphism of clinical manifestations, functional prognosis and differentiated approach to treatment depending on the prevailing clinical symptoms, we suggest a new variant of clinical classification of Coats retinitis. Conclusion. In order to ensure a timely diagnosis of the disease, a very thorough examination of patients in the first decade of life is required. Only an early diagnosis and timely treatment can help achieve not only an eye-preserving effect but also functional results.

1. Gurko T.S., Goydin A.P. Clinical features and treatment of Coates retinitis. Bulletin of the Tambov University. Series: Natural and technical sciences. 2017; 22 (4): 638–42 (in Russian). doi: 10/20310/1810-0198-2017-22-4-63 8-642

2. Coats G. Forms of retinal diseases with massive exudation. Roy Lond Ophthalmol. Hosp. Rep. 1908; 17: 440–525.

3. Ghorbanian S., Jaulim A., Chatziralli I.P. Diagnosis and treatment of coats' disease: a review of the literature. Ophthalmologica. 2012; 227 (4): 175–82. doi: 10.1159/000336906

4. Shields J.A., Shields C.L., Honavar S.G., Demirci H. Clinical variations and complications of Coats’ disease in 150 cases: The 2000 Sanford Gifford Memorial lecture. Am. J. Ophthalmol. 2001; 131 (5): 561–71. doi: 10.1016/ s0002-9394(00)00883-7

5. Fernandes B.F., Odashiro A.N., Maloney S., et al. Clinical-histopathological correlation in a case of Сoats’disease. Diagn. pathol. 2006; 1: 24. doi: 10.1186/1746-1596-1-24

6. He Y.G., Wang H., Zhao B., et al. Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab. Graefes Arch. Clin. Exp. Ophthalmol. 2010; 248 (10): 1519–21. doi: 10.1007/s00417-010-1366-1

7. Katsnel'son L.A., Forofonova T.I., Bunin A.Ya. Vascular eye diseases. Moscow: Meditsina; 1990 (in Russian).

8. Adam R.S., Kertes P.J., Lam W-Ch. Оbservations on the management of Coats’ disease: less is more. Br. J. Оphthalmol. 2007. 91 (3): 303–6. doi: 10.1136/ bjo.2006.103382

9. Joussen A.M., Gordes R.S., Heuben R.A., Muller B. [Retinal exudative disease in childhood: Coats’ disease and familian exudative vitreoretinopathy (FEVR)]. Klin. Monbl. Augenheilkd. 2013; 230 (9): 902–13. doi: 10.1055/s-0033-1350689

10. Sen M., Shields C.L., Hanavar S.G., Shields J.A. Coats’ disease: an overview of classification, management and outcomes. Indian J. Ophthalmol. 2019 67 (6) 763–77. doi. 10.4103/ijo.IJO_841_19

11. Daruich A.L., Moulin A.P., Tran Hoai V., Matet A., Munier F L. Subfoveal nodule in Coats’disease. Retina. 2017; 37 (8): 1591–8. doi: 10.1097/IAE. 0000000000001399

12. Jumper J.M., Pomerleau D., McDonald H.R., et al. Macular fibrosis in Coats disease. Retina 2010; 30 (4): 9–14. doi: 10.1097/iae.0b013e3181cfd3e7

13. Shields J.A., Shields C.L., Honavar S.G., Demirci H., Cater J. Classification and management of Coats’ diseases: the 2000. Proctor lecture. Am. J. Ophthalmol.; 2001. 131 (5): 572–83. doi: 10.1016/s0002-9394(01)00896-0

14. Shamshinova A.M., ed. Hereditary and congenital diseases of the retina and optic nerve. Moscow: Meditsina; 2001 (in Russian).

15. Shchuko A.G., Bukina V.V., Yur'eva T.N., Zlobina A.N. Tactics of management of patients with Coats' disease. Sovremennye tekhnologii v oftal'mologii. 2017; 14 (1): 359–62 (in Russian).

16. Bergstrom C.S., Hubbard G.B., 3rd. Combination intravitreal triamcinolone injection and cryotherapy for exudative retinal detachments in severe Coats disease. Retina. 2008; 28 (3): 33–7. doi: 10.1097/IAE.0b013e318159ecad

17. Ray R., Barañano D.E., Hubbard G.B. Treatment of Coats' disease with intravitreal bevacizumab. Br. J. Ophthalmol. 2013; 97 (3): 272–7. doi: 10.1136/ bjophthalmol-2012-302250

18. Denisova E.V., Katargina L.A., Kogoleva L.V., et al. Eye damage in Landuzi-Dejerin disease (case description and literature review). Russian ophthalmological journal. 2018; 11 (3): 50–4 (in Russian). doi:10.21516/2072-0076-2018-11- 3-50-54

19. Katargina L.A., Kogoleva L.V., Belova M.V., Tarasenkov A.O. Late vitreoretinal complications of retinopathy of prematurity: diagnosis and treatment tactics. Oftal'mokhirurgiya. 2018; 1: 31–6 (in Russian). doi: 10.25276/0235-4160-2018-1-31-36

20. Shields J., Shields C. Intraocular tumors. An Atlas and textbook. Lippincott Williams Wilkins; 2008.